CLINICAL_TRIALS
trial_result
· 2016-10-28
Clinical Trial Update: Evaluation of Vepoloxamer in Chronic Heart Failure [Phase 2]
Summary
A Phase 2 trial of Vepoloxamer for chronic heart failure was terminated before completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mast Therapeutics, Inc. | Conditions: Chronic Heart Failure | Phase 2 | Status: TERMINATED